臨床試驗進度

Pipeline Indication Region CAR engineering Pre-clinical Phase I Phase II/ III
UBP-3001
(UWC19)
B cell
malignancies
China First in human
UBP-3002
(UWC19)
Non-Hodgkin
lymphoma
Taiwan
UBP-3003
(UWC19)
B cell
malignancies
Malaysia
UBP-3004
(UWC19)
Lymphoblastic
leukemia
Taiwan
UBP-3005
(UWC19)
Non-Hodgkin
lymphoma
China
UBP-Her2-CART
(UWHer2T)
Solid tumour Taiwan
UBP-alloNK-19
(UWC19-aNK)
B cell
malignancies
Taiwan
UBP-alloNK-Her2 Solid tumour Taiwan

登入

登入成功